Pharmacokinetics of transperitoneal insulin transport?

Nephron

Volumn 74, Issue 2, 1996, Pages 283-290

  Widerøe, Tor Erik ^a   Dahl, Ketil J ^a   Smeby, Leif C ^b   Balstad, Torveig ^a   Cruischank Flakne, Sidsel ^a   Foiling, Ivar ^a   Simondsen, Ole ^c   Ahlmen, Jarl ^d   Jorstad, Starker ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b Gambro AB   (Norway)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d Department of Nephrology ^*  (Sweden)

Author keywords

Insulin kinetic; Peritoneal dialysis; Transperitoneal insulin transport

Indexed keywords

GLUCOSE; INSULIN; NEUTRAL INSULIN; RADIOIODINATED HUMAN SERUM ALBUMIN; RINGER LACTATE SOLUTION;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSATE; DILUTION; DRUG BIOAVAILABILITY; DRUG ELIMINATION; DRUG TRANSPORT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; OSMOLALITY; PERITONEAL CAVITY; PRIORITY JOURNAL;

EID: 0029794353     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189322     Document Type: Article

References (27)

1. Shapiro DJ. Blumenkrantz MJ. Levin SR. Coburn JW: Absorption and action of insulin added to peritoneal dialysate in dogs. Nephron 1979;23:174-180.
2. Rubin J, Reed V, Adair C, Bower J. Klein E: Effects of intraperitoneal insulin on solute kinetics in CAPD: insulin kinetics in CAPD. Am JSci 1986;291:81-87.
3. 51 insulin absorption during intermittent and continuous peritoneal dialysis. Kidney Int 1983:23:22-28.
4. Widcroe T-E. Smeby LC. Myking OL: Plasma concentrations and transperitoncal transport of native insulin and C-pcptide in patients on continuous ambulatory peritoneal dialysis. Kidney lnt 1984:25:82-87.
5. Schade DS. Eaton RP. Davis T. Akiya F. Phin-ney E. Kubica R. Vaughn EA. Day PW: The kinetics of peritoneal insulin absorption. Metabolism 1981;30:149-155.
6. Sacca L. Orofino G. Petrone A, Vigorito C: Direct assessment of splanchnic uptake and metabolic effects of human and porcine insulin. J Clin Endocrinol Mctab 1984:59:191-196.
7. Jimenez JT. Walford S. Home PD, Hanning I. Alberti KGMM: Free insulin levels and metabolic effects of meal-time bolus and square-wave intraperitoneal insulin infusion in insulin-dependent patients. Diabctologia 1985:28: 728-733.
8. Schade DS, Eaton P: The peritoneum-A potential insulin delivery route for a mechanical pancreas. Diabetes Care 1980:3:229-234.
9. Simon JD. Antoniades HN: Transport of peptide hormones across isolated rat mesentery: Effect of human serum-bound insulin. Diabetes 1975;24:997-1004.
10. 125I-insulin across isolated mesentery: Effect of anti-insulin scrum. Biochim Biophys Acta 1969; 183:162- 168.
11. Amair P. Khanna R. Leibel B, et al: Continuous ambulatory peritoneal dialysis in diabetic patients with end-stage renal disease. N Engl J Med 1982:306:625-630.
12. Flynn CT. Nanson JA: Intraperitoneal insulin with CAPD-An artificial pancreas. Trans ASAIO 1979;25:111-117.
13. Madden MA. Zimmerman SW, Simpson DP: CAPD in diabetes mellitus-The risks and benefits of intraperitoneal insulin. Am J Nephrol 1982:2:133-139.
14. Hanning I. Home PD. Alberti KGM: Measurement of free insulin concentrations: The influence of the timing of extraction of insulin antibodies. Diabetologia 1985:28:831-835.
15. Leypoldt JK, Pust AH. Frigon RP. Henderson LW: Dialysate volume measurements required for determining peritoneal solute transport. Kidney Int 1988:34:254-261.
16. Pust AH. Leypoldt JK. Frigon RP. Henderson LW: Peritoneal dialysate volume determined by indicator dilution measurements. Kidney Int 1988;33:64-70.
17. Lindholm B. Werynski A. Traneus A, Oster-berg T, Bergstrom J: Kinetics of peritoneal dialysis with amino acids as osmotic agents. Trails ASAIO 1987:33:19-27.
18. Rippe B. Perry MA. Granger DNA: Permselcc-tivity of the peritoneal membrane. Microvasc Res 1985:29:89-102.
19. Rippe B. Stelin G: Simulations of peritoneal solute transport during CAPD. Application of two-pare formalism. Kidney lnt 1989;35: 1234-1244.
20. Smeby LC, Widcroe T-E: Kinetics of continuous ambulatory peritoneal dialysis. Proc Eur Soc Art if Organs 1979:6:156-160.
21. Balducci A, Slama G. Rotlcnburg J. Baumelou A. Delage A: Intraperitoneal insulin in uremic diabetics undergoing continuous peritoneal dialysis Br Med J 1981;283:1021-1023.
22. Daug rdas JT, Ing TS, Gandhi VC. I laño JE, Chen W-T, Yuan L: Kinetics of peritoneal fluid absorption in patients with chronic renal failure. J Lab Clin Med 1980:95:351-361.
23. Pust AH. Leypoldt JK. Frigon RP. Henderson LW: Peritoneal dialysate volume determined by indicator dilution measurements. Kidney Int 1988:33:64-70.
24. Mactier R, Khanna R, Twardowski Z. Nolph KD: Estimation of lymphatic absorption and intraperitoneal volume during hypertonic peritoneal dialysis. Trans ASAIO 1988:34:82-83.
25. Rippe B. Stelin G. Ahlmen J: Lymph flow' from the peritoneal cavity in CAPD patients; in Maher JF. Winchester JF (eds): Frontiers in Peritoneal Dialysis. New York. Field Rich & Associates, Inc, 1986, pp 24-30.
26. Peetoom JJ. Willekens FLA, Meindcrs AE: Absorption and biological effect of intraperitoneal insulin administration in patients with terminal renal failure treated by continuous ambulatory peritoneal dialysis. Neth J Med 1985:28: 435-441.
27. Frost DP. Srivastava MC, Jones RH. Nabarro JDN. Sonksen Pl-1: The kinetics of insulin metabolism in diabetes mellitus. Postgrad Med J 1973:49 (suppl):949-954.